NTI 1.69% 5.8¢ neurotech international limited

News: NTI Neurotech International Seeks Trading Halt

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    May 3 (Reuters) - Neurotech International Ltd (NTI) :

    • SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF PHASE I/II RETT SYNDROME CLINICAL TRIAL.
    • REQUESTS TRADING HALT PENDING RELEASE OF FULL RESULTS OF COMPANY'S PHASE I/II RETT SYNDROME CLINICAL TRIAL.

    (([email protected];))

 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.